Previous 10 | Next 10 |
REDWOOD CITY, CA / ACCESSWIRE / April 21, 2023 / Biotricity Inc. (NASDAQ:BTCY), a medical technology company committed to improving healthcare by developing solutions that aid in chronic disease prevention and management, is taking action to tackle the unmet need in cardiovascular diseases (CV...
2023-04-19 09:40:15 ET Biotricity ( NASDAQ: BTCY ) reached a record $12M annualized revenue run rate in March 2023. The company attributed its strengthening financials to the growing sales of its product line of remote cardiac monitors spanning consumers to cardiologists, ...
REDWOOD CITY, CA / ACCESSWIRE / April 19, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a leading medical diagnostic and consumer healthcare technology company, today reported that it reached a record $12 million annualized revenue run rate in March 2023. Based on prel...
"Inducing Better Patient Outcomes, Substantial Cost Savings" REDWOOD CITY, CA / ACCESSWIRE / April 11, 2023 / Biotricity, Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a leading medical diagnostic and consumer healthcare technology company, has released its first Corporate Impact Rep...
Highlights Several Major Operating Milestones Since FY22 REDWOOD CITY, CA / ACCESSWIRE / March 7, 2023 / Biotricity, Inc. (Nasdaq:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, has not only been establishing a significant market foot...
Biotricity, Inc. (BTCY) Q3 2023 Earnings Conference Call February 14, 2023, 04:30 PM ET Company Participants Debra Chen - Investor Relations Waqaas Al-Siddiq - Founder & Chief Executive Officer John Ayanoglou - Chief Financial Officer Conference Call Particip...
Biotricity press release ( NASDAQ: BTCY ): Q3 GAAP EPS of -$0.09 in-line. Revenue of $2.46M (+27.5% Y/Y) beats by $0.06M . For further details see: Biotricity GAAP EPS of -$0.09 in-line, revenue of $2.46M beats by $0.06M
Revenue Up 27.4% YOY Enviable 98% Customer Retention Rate Drives Subscription Recurring Rev Growth Two Major Distribution Agreements Implemented Net Loss Narrowed by One Third as Company Targets Positive Cash Flow Investor Teleconference Scheduled Today for 4:30 ET REDWOO...
REDWOOD CITY, CA / ACCESSWIRE / February 9, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced it will host a conference call on Tuesday, February 14 th , 2023 at 4:30 p.m. ET to discuss its fin...
The Wearable Medical Devices Market size is expected to be worth around USD 196.7 billion by 2030 valued at USD 21.7 billion in 2021 and growing at a CAGR of 28.3% during the forecast period from 2022 to 2030. This comprehensive analysis of the fastest-growing Wearable Medical...
News, Short Squeeze, Breakout and More Instantly...
ORLANDO, FL / ACCESSWIRE / July 12, 2024 / RedChip Companies will air interviews with Biotricity, Inc. (Nasdaq:BTCY) and bioAffinity Technologies, Inc. (Nasdaq:BIAF) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 13, at 7 p.m. East...
REDWOOD CITY, CA / ACCESSWIRE / July 11, 2024 / Biotricity Inc. (NASDAQ:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced its accelerated timeline to achieving EBITDA positive. The company now expects to reach t...
REDWOOD CITY, CA / ACCESSWIRE / July 10, 2024 / Biotricity Inc. (Nasdaq:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced the launch of a new cardiac monitoring pilot program with a prominent hospital group enco...